Use of a baseline risk score to identify the risk of serious infectious events in patients with rheumatoid arthritis during certolizumab pegol treatment

Jeffrey R. Curtis, Kevin Winthrop, Cathy O'Brien, Matladi N. Ndlovu, Marc de Longueville, Boulos Haraoui

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint Dive into the research topics of 'Use of a baseline risk score to identify the risk of serious infectious events in patients with rheumatoid arthritis during certolizumab pegol treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences